Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Northrop Grumman Corporation (NOC) vs UiPath Inc (PATH) Price & Performance

Northrop Grumman CorporationTrade
UiPath IncTrade

Price performance (Past 24H)

Key statistics

Northrop Grumman Corporation vs UiPath Inc — how do they compare? Northrop Grumman Corporation trades at $481.08 (market cap $68.83B), while UiPath Inc trades at $13.34 (market cap $6.91B). The key difference: Northrop Grumman Corporation is far larger — about 10× UiPath Inc's market cap, and Northrop Grumman Corporation pays a 2.04% dividend while UiPath Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Northrop Grumman Corporation for 81 Days and UiPath Inc for 139 Days on average.

NOCPATH
Market Cap
$68.83B$6.91B
Volume
1,081,98934,321,250
Sector
IndustrialsTechnology
52-Week High
$768.02$19.29
52-Week Low
$473.46$9.38
Typical Hold Time
81 Days139 Days
Enterprise Value
$82.81B$5.70B
Dividend Yield
2.04%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Northrop Grumman Corporation

Northrop Grumman (NOC) trades at $473.46, down 2.0% on the day, reflecting a bearish technical signal amid recent contract loss news. The stock exhibits strong fundamentals with a P/E of 15.05, net income margin of 10.48%, and consistent earnings beats in recent quarters. Revenue growth is steady, supported by a record backlog, though the loss of the $20 billion Navy F/A-XX contract to Boeing introduces competitive pressure.

The outlook remains supported by robust defense budgets and key programs like the B-21 bomber, but investor sentiment is cautious near-term. Analyst consensus is bullish with a $600.62 price target, though technical indicators suggest potential near-term weakness. Risks include contract dependencies and macroeconomic shifts in defense spending.

UiPath Inc

UiPath (PATH) trades at $13.07, down 0.23% on the day, amid a bearish technical signal and mixed earnings history. The company shows improving fundamentals with revenue growing from $1.43B in 2025 to a projected $1.7B in 2026, while net income is expected to turn positive. Recent news highlights AI partnerships and product innovations, but the stock faces headwinds from cautious analyst sentiment and technical resistance.

The outlook for PATH is cautiously optimistic, with strong revenue growth and a path to profitability offering upside potential, but risks include execution challenges and competitive pressures. The consensus price target of $15.13 suggests moderate upside from current levels, though investor sentiment remains divided.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NOC
100% Buy0% Sell
Avg holding period · 81 Days
PATH
47% Buy53% Sell
Avg holding period · 139 Days

Top news

Latest headlines on both assets

About Northrop Grumman Corporation

Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.

Read more on NOC →

About UiPath Inc

UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.

Read more on PATH →